» Articles » PMID: 26925077

Optimized Blanching Reduces the Host Cell Protein Content and Substantially Enhances the Recovery and Stability of Two Plant-Derived Malaria Vaccine Candidates

Overview
Journal Front Plant Sci
Date 2016 Mar 1
PMID 26925077
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Plants provide an advantageous expression platform for biopharmaceutical proteins because of their low pathogen burden and potential for inexpensive, large-scale production. However, the purification of target proteins can be challenging due to issues with extraction, the removal of host cell proteins (HCPs), and low expression levels. The heat treatment of crude extracts can reduce the quantity of HCPs by precipitation thus increasing the purity of the target protein and streamlining downstream purification. In the overall context of downstream process (DSP) development for plant-derived malaria vaccine candidates, we applied a design-of-experiments approach to enhance HCP precipitation from Nicotiana benthamiana extracts generated after transient expression, using temperatures in the 20-80°C range, pH values of 3.0-8.0 and incubation times of 0-60 min. We also investigated the recovery of two protein-based malaria vaccine candidates under these conditions and determined their stability in the heat-treated extract while it was maintained at room temperature for 24 h. The heat precipitation of HCPs was also carried out by blanching intact plants in water or buffer prior to extraction in a blender. Our data show that all the heat precipitation methods reduced the amount of HCP in the crude plant extracts by more than 80%, simplifying the subsequent DSP steps. Furthermore, when the heat treatment was performed at 80°C rather than 65°C, both malaria vaccine candidates were more stable after extraction and the recovery of both proteins increased by more than 30%.

Citing Articles

Product safety aspects of plant molecular farming.

Buyel J Front Bioeng Biotechnol. 2023; 11:1238917.

PMID: 37614627 PMC: 10442644. DOI: 10.3389/fbioe.2023.1238917.


Design, optimization, production and activity testing of recombinant immunotoxins expressed in plants and plant cells for the treatment of monocytic leukemia.

Knodler M, Frank K, Kerpen L, Buyel J Bioengineered. 2023; 14(1):2244235.

PMID: 37598369 PMC: 10444015. DOI: 10.1080/21655979.2023.2244235.


Risk assessment and bioburden evaluation of Agrobacterium tumefaciens-mediated transient protein expression in plants using the CaMV35S promoter.

Knodler M, Reunious P, Buyel J BMC Biotechnol. 2023; 23(1):14.

PMID: 37286972 PMC: 10246419. DOI: 10.1186/s12896-023-00782-w.


Optimising expression and extraction of recombinant proteins in plants.

Coates R, Young M, Scofield S Front Plant Sci. 2022; 13:1074531.

PMID: 36570881 PMC: 9773421. DOI: 10.3389/fpls.2022.1074531.


Enhanced HIV SOSIP Envelope yields in plants through transient co-expression of peptidyl-prolyl isomerase B and calreticulin chaperones and ER targeting.

Rosenberg Y, Jiang X, Lees J, Urban L, Mao L, Sack M Sci Rep. 2022; 12(1):10027.

PMID: 35705669 PMC: 9200074. DOI: 10.1038/s41598-022-14075-3.


References
1.
Daniell H, Streatfield S, Wycoff K . Medical molecular farming: production of antibodies, biopharmaceuticals and edible vaccines in plants. Trends Plant Sci. 2001; 6(5):219-26. PMC: 5496653. DOI: 10.1016/s1360-1385(01)01922-7. View

2.
Voepel N, Boes A, Edgue G, Beiss V, Kapelski S, Reimann A . Malaria vaccine candidate antigen targeting the pre-erythrocytic stage of Plasmodium falciparum produced at high level in plants. Biotechnol J. 2014; 9(11):1435-45. DOI: 10.1002/biot.201400350. View

3.
Boes A, Spiegel H, Voepel N, Edgue G, Beiss V, Kapelski S . Analysis of a Multi-component Multi-stage Malaria Vaccine Candidate--Tackling the Cocktail Challenge. PLoS One. 2015; 10(7):e0131456. PMC: 4492585. DOI: 10.1371/journal.pone.0131456. View

4.
Simonian M, Smith J . Spectrophotometric and colorimetric determination of protein concentration. Curr Protoc Mol Biol. 2008; Chapter 10:Unit 10.1A. DOI: 10.1002/0471142727.mb1001as76. View

5.
Callaway E, Maxmen A . Malaria vaccine cautiously recommended for use in Africa. Nature. 2015; 526(7575):617-8. DOI: 10.1038/nature.2015.18638. View